m********o
发帖数: 2088 | 1 LOL. They are still pumping ^_^
Oracle Investment Research is going full out contrarian on Molycorp (NYSE:
MCP).
Although shares are in a death spiral, Oracle is upgrading shares from Buy
to Strong Buy with a price target of $50.00.
The firm notes that MCP is below the IPO price and below paid-in capital.
MCP has raised a total of ~$2.3 billion, and at today's price shares are at
a market cap of $1.1 billion.
They also note spot prices of REOs' are stable "and showing signs of a mild
pick up." "With production quotas from China estimated to drop by 20% to
80kMT in 2013, timing of MCP to ramp up production is fortuitous."
"This raise, which we estimate to be the last, puts MCP in a comfortable
cash position."
For an analyst ratings summary and ratings history on Molycorp click here.
For more ratings news on Molycorp click here.
Shares of Molycorp are down 10 percent today after the capital raise and
downgrade at Dahlman Rose. |
|
